Dr. Nasser Algahtani

Dr.Nasser Alqahtani works for Roche Pharma – Saudi Arabia as a country medical director. In his 17 years journey with the government, his precedent role was with the first Central Health Cluster – Ministry Of Health (MOH) as an executive director for drug and pharmaceutical affairs and an acting executive director for population health management directorate.

He is one of the Alfaisal University’s faculty members and works as an adjunct assistant professor of pharmacoepidemiology and Pharmacoeconomics

He used to serve as a director for drug safety and risk management deAdd Newpt at Saudi Food and Drug Authority (SFDA) for 13 consecutive years.

He receives his B.S. in Pharmacy from King Saud University, M.Sc. in clinical pharmacy from the UCL – UK and Ph.D. in pharmaceutical policy and outcomes research (Major: Pharmacoepidemiology) from Auburn University – Alabama, USA. He holds a certificate of higher diploma in pharmacovigilance and pharmacoepidemiology from London School of Hygiene and Tropical Medicine (LSHTM).

He is a member of a couple of professional societies. Besides, he used to chair the national evidence-based practice committee at Saudi Health Council (SHC).

He is a reviewer for a number of peer-reviewed journals and he used to chair the scientific committee of the SFDA’s research center, and acts as a senior research associate for the medication safety research chair-KSU. Dr. Alqahtani is a research collaborator with the Observational Health Data Sciences and Informatics (OHDSI) organization housed by Columbia University – New York, USA

His area of research focuses on the development and application of epidemiologic and statistical methods for evaluating the safety of medical products in large healthcare databases.